$1.00
+0.00 (+0.02%)
Open$0.99
Previous Close$1.00
Day High$1.03
Day Low$0.96
52W High$1.19
52W Low$0.56
Volume—
Avg Volume218.2K
Market Cap12.64M
P/E Ratio—
EPS$-1.11
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+4,355.6% upside
Current
$1.00
$1.00
Target
$44.56
$44.56
$28.75
$44.56 avg
$50.07
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 52.49M | 46.33M | 1.67M |
| Net Income | -13,261,703 | -10,533,521 | 470.0K |
| Profit Margin | -25.3% | -24.0% | 28.1% |
| EBITDA | -14,110,564 | -11,830,408 | 856.8K |
| Free Cash Flow | — | — | 585.2K |
| Rev Growth | +13.3% | +13.3% | +24.3% |
| Debt/Equity | 0.44 | 0.44 | 0.16 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,124.85 | +0.68% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $245.14 | +1.72% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $124.71 | +3.41% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $23.83 | -0.87% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $77.65 | -0.67% | 12.5 | 33.00B |